Menu
J. Coy Stull
  • J. Coy Stull
  • 813.229.4120
  • Share this page
J. Coy Stull

J. Coy Stull

Of Counsel
In this section

Overview

Coy Stull is an intellectual property attorney with experience in all stages of federal court litigation, including trials and appeals.

Coy represents both owners and accused infringers in federal district courts, the International Trade Commission, and Patent and Trademark Office administrative proceedings (PTAB/TTAB). He litigates cases in a wide variety of technological areas, including consumer products, industrial processes, nanomaterials, polymers, pharmaceutical compositions, methods of drug delivery and treatment, small molecules, natural products, medical diagnostic devices, and veterinary products. Coy has extensive experience in life science technologies, including pharmaceutical litigation related to the Hatch-Waxman Act. Coy also handles trademark, copyright, and unfair competition disputes, including opposition and cancellation proceedings before the Trademark Trial and Appeal Board. A registered patent attorney, Coy advises clients regarding patent and trademark applications, prosecution, inter partes review (IPR), and ex parte reexaminations. Coy also prepares opinions relating to infringement and validity.

Outside of his intellectual property practice, Coy devotes a significant amount of time to pro bono matters. He has represented several veterans seeking service-related disability benefits before the U.S. Court of Appeals for Veterans Claims. He also has represented tenants and family law clients at trial and hearings in the Superior Court of the District of Columbia. Coy frequently volunteers at the D.C. Bar Pro Bono Center’s Landlord and Tenant Resource Center and Small Business Advice Clinics.

Experience

  • Nichia Corporation in Nichia Corp. v. Lighting Science Group in a patent infringement litigation in the Middle District of Florida concerning semiconductor light-emitting devices.
  • Hunt Construction and USTA National Tennis Center in Uni-Systems, LLC v. USTA, a multiparty patent litigation in the Eastern District of New York concerning retractable stadium roofs.
  • Qidong Vision Mounts Manufacturing Co. Ltd. in post-grant review proceedings involving a patent for an adjustable desk platform (PGR2019-00020).
  • Respondent Qidong Vision Mounts Manufacturing Co. Ltd. in Certain Height-Adjustable Desk Platforms and Components Thereof (ITC, Inv. No. 337-TA-1125).
  • Dr. Reddy’s Laboratories in Indivior Inc. v. Dr. Reddy’s Laboratories, S.A., Hatch-Waxman patent infringement litigations in the District of Delaware, the District of New Jersey, and the Federal Circuit involving patents listed in the Orange Book for Suboxone® (buprenorphine/naloxone sublingual film).
  • Dr. Reddy’s Laboratories in inter partes review proceedings involving an Orange Book patent for Suboxone® (IPR2019-00328, IPR2019-00329).
  • Fresenius Kabi USA in Shire Orphan Therapies LLC v. Fresenius Kabi USA, LLC, a Hatch-Waxman patent infringement litigation in the District of Delaware and the Federal Circuit involving a patent listed in the Orange Book for Firazyr® (icatibant acetate).
  • West-Ward Pharmaceuticals and Eurohealth International in Helsinn Healthcare S.A. v. Cipla Ltd., a Hatch-Waxman patent infringement litigation involving patents listed in the Orange Book for Aloxi® (palonosetron hydrochloride).
  • Ceva Santé Animale and Horizon Valley Generics in Merial Inc. v. Ceva Santé Animale S.A., a contract and Lanham Act litigation in the Middle District of Georgia involving fiproniI/methoprene veterinary products.
  • West-Ward Pharmaceuticals and Eurohealth International in Spectrum Pharmaceuticals Inc. v. Eurohealth International Sarl, a Hatch-Waxman patent infringement litigation in the District of Nevada involving an Orange Book patent listed for Fusilev® (Ievoleucovorin).
  • Fresenius Kabi USA in Cubist Pharmaceuticals LLC v. Fresenius Kabi USA, LLC, a Hatch-Waxman patent infringement litigation in the District of Delaware involving Orange Book patents listed for Cubicin® (daptomycin for injection).
  • Respondent Enzymotec in Omega-3 Extracts From Marine or Aquatic Biomass and Products Containing the Same (ITC Inv. No. 337-TA-877).
  • Watson Laboratories and Actavis Laboratories in Bayer Pharma AG v. Watson Laboratories Inc., Hatch-Waxman patent infringement litigations in the District of Delaware and the District of New Jersey involving patents listed in the Orange Book for Staxyn® (vardenafil).
  • HSN LP in TTAB proceedings against Andrew Rothlein (No. 91183879).
  • Watson Laboratories and Andrx Labs in Purdue Pharma, L.P. v. Watson Laboratories Inc., Hatch-Waxman patent infringement litigations in the Southern District of New York involving patents listed in the Orange Book for OxyContin® (extended-release oxycodone hydrochloride tablets).
  • Trademark owner Mattel Inc. in TTAB proceedings against Brainy Baby Company LLC (No. 92052047).
  • Watson Laboratories in Pfizer Inc. v. Watson Pharmaceuticals Inc., a Hatch-Waxman patent infringement litigation in the District of Delaware involving a patent listed in the Orange Book for Rapamune® (sirolimus).
  • Trademark owner Mattel Inc. in TTAB proceedings against S.W. Fantasies Inc. (No. 91170977).
  • Impax Laboratories Inc. in Abbott Laboratories v. Impax Laboratories Inc. and Elan Pharma International Ltd. v. Impax Laboratories Inc., Hatch-Waxman patent infringement litigations in the District of New Jersey involving patents listed in the Orange Book for Tricor® (fenofibrate).
  • HSN LP, Ingenious Designs LLC, and Joy Mangano in Pearson v. HSN LP, a patent infringement litigation in the Western District of Tennessee involving bedclothes.
  • Fisher-Price and Mattel in Ottis v. Fisher-Price, a copyright infringement litigation involving Planet Heroes® line of toys.
  • Impax Laboratories Inc. in Purdue Pharma Products LP v. Impax Laboratories Inc. and In re Tramadol Hydrochloride Extended-Release Tablets Patent Litigation, Hatch-Waxman patent infringement litigations in the District of Delaware involving patents listed in the Orange Book for Ultram ER (extended-release tramadol hydrochloride).

Professional & Community Involvement

  • Federal Circuit Bar Association
  • PTAB Bar Association

Pro Bono

  • Lead counsel for veterans in benefits appeals at the U.S. Court of Appeals for Veterans Claims.
  • Lead counsel for tenants in a housing conditions and eviction case in the Superior Court of the District of Columbia.
  • Lead counsel for homeless client in a child custody and protective order case in the Superior Court of the District of Columbia.

Credentials

Education
  • University of Miami School of Law (J.D., cum laude, 2005)
  • University of Florida (B.S., with honors, 2002)
Bar Admissions
  • District of Columbia
  • Florida
  • U.S. Patent and Trademark Office
Court Admissions
  • U.S. Supreme Court
  • U.S. Court of Appeals, Federal Circuit
  • U.S. Court of Appeals for Veterans Claims
  • U.S. District Court, Middle District of Florida
  • U.S. District Court, Northern District of Florida
  • U.S. District Court, Southern District of Florida

Background

  • Senior Attorney, Goodwin Procter LLP, Washington, D.C. (2014–2019)
  • Associate, Kenyon & Kenyon, Washington, D.C. (2008–2014)

Cookies

This site uses cookies to provide you with more responsive and personalized service. By using this site you agree to our Legal Disclaimer and Online Privacy and Cookie Policy. 

I Accept
©2011-2019 Carlton Fields, P.A. Carlton Fields practices law in California through Carlton Fields, LLP. All Rights Reserved. Attorney Advertising.

Disclaimer

The information on this website is presented as a service for our clients and Internet users and is not intended to be legal advice, nor should you consider it as such. Although we welcome your inquiries, please keep in mind that merely contacting us will not establish an attorney-client relationship between us. Consequently, you should not convey any confidential information to us until a formal attorney-client relationship has been established. Please remember that electronic correspondence on the internet is not secure and that you should not include sensitive or confidential information in messages. With that in mind, we look forward to hearing from you.
Accept Cancel